Saturday, April 19, 2025
31.7 C
Bengaluru

Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action

The MedicinMan 10th Anniversary Special – Pharma CEO Roundtable 2021 Series 2 is Now Live

Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action

Keynote Speaker: Dr. Mahender Nayak, Senior VP / Head of ICMEA* Region (India, Turkey, CIS Countries, Ukraine, Middle East & Africa) at Takeda.

Panel Members: Prakash Maheshwari, Vice President, Glenmark: Strategic Leadership | Pill+Service | Building Talent | Change Management | Risk-Taking & Innovation.

Sourabh Agrawal, Vice President – Sales & Marketing at Lupin Global.

Salil Kallianpur, Executive Editor of MedicinMan and former Executive VP – Emerging Markets at GSK.

Praful Akali, MD at Medulla Communications

– https://youtu.be/fYYdoXHBaW8 via YouTube

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img